Work

Supplementary Table S2 from A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table S2. The 71 microRNAs expressed in at least 75% of the samples in the training cohort

DOI: 10.1158/1078-0432.22461011

Authors: Kristine Kleivi Sahlberg, Giulia Bottai, Bjørn Naume, Barbara Burwinkel, George A. Calin, Anne-Lise Børresen-Dale, Libero Santarpia

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361884872

Cites:

Cited by:

Related to: 10